Haleon plc (HLNCF)

Market Cap	44.71B -1.6%
Revenue (ttm)	14.85B -1.8%
Net Income	2.24B +15.6%
EPS	0.25 +17.8%
Shares Out	n/a
PE Ratio	19.93
Forward PE	18.31
Dividend	0.09 (1.81%)
Ex-Dividend Date	Aug 14, 2025

Volume	1,111
Average Volume	19,784
Open	5.01
Previous Close	5.11
Day's Range	5.01 - 5.02
52-Week Range	4.25 - 5.80
Beta	0.22
RSI	43.83
Earnings Date	Feb 25, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,561
• Stock Exchange: OTCMKTS
• Ticker Symbol: HLNCF

Financial Performance

In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.

Financial numbers in GBP